Market revenue in 2023 | USD 13,628.7 million |
Market revenue in 2030 | USD 22,052.5 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Liquid delivery device |
Fastest growing segment | Liquid Delivery Device |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Powder delivery device, Liquid Delivery Device, Pressurized Metered Dose Inhaler |
Key market players worldwide | GSK PLC ADR, Teva Pharmaceutical Industries Ltd, AptarGroup Inc, UCB SA, Teleflex Inc, 3M Co, OptiNose Inc, Bespak, Intersect ENT |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intranasal drug and vaccine delivery market will help companies and investors design strategic landscapes.
Liquid delivery device was the largest segment with a revenue share of 43.33% in 2023. Horizon Databook has segmented the Asia Pacific intranasal drug and vaccine delivery market based on powder delivery device, liquid delivery device, pressurized metered dose inhaler covering the revenue growth of each sub-segment from 2018 to 2030.
The intranasal drug and vaccine delivery market in Asia Pacific is anticipated to witness significant growth over the forecast period. Presence of developing countries such as China, India, and Japan is anticipated to boost market growth in Asia Pacific. These economies are now engaging in international trade through foreign direct investment.
In addition, rapidly growing medical tourism industry in these countries can also be attributed to the increase in the demand for various products used in intranasal drug and vaccine delivery in this region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific intranasal drug and vaccine delivery market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific intranasal drug and vaccine delivery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account